Literature DB >> 33002578

Effect of alanine supplementation on oxalate synthesis.

Kyle D Wood1, Brian L Freeman2, Mary E Killian3, Win Shun Lai4, Dean Assimos1, John Knight1, Sonia Fargue5.   

Abstract

The Primary Hyperoxalurias (PH) are rare disorders of metabolism leading to excessive endogenous synthesis of oxalate and recurring calcium oxalate kidney stones. Alanine glyoxylate aminotransferase (AGT), deficient in PH type 1, is a key enzyme in limiting glyoxylate oxidation to oxalate. The affinity of AGT for its co-substrate, alanine, is low suggesting that its metabolic activity could be sub-optimal in vivo. To test this hypothesis, we examined the effect of L-alanine supplementation on oxalate synthesis in cell culture and in mouse models of Primary Hyperoxaluria Type 1 (Agxt KO), Type 2 (Grhpr KO) and in wild-type mice. Our results demonstrated that increasing L-alanine in cells decreased synthesis of oxalate and increased viability of cells expressing GO and AGT when incubated with glycolate. In both wild type and Grhpr KO male and female mice, supplementation with 10% dietary L-alanine significantly decreased urinary oxalate excretion ~30% compared to baseline levels. This study demonstrates that increasing the availability of L-alanine can increase the metabolic efficiency of AGT and reduce oxalate synthesis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alanine; Alanine:glyoxylate aminotransferase; Kidney stones; Oxalate; Primary hyperoxaluria

Mesh:

Substances:

Year:  2020        PMID: 33002578      PMCID: PMC7722081          DOI: 10.1016/j.bbadis.2020.165981

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  42 in total

1.  Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.

Authors:  T Y Saleh; P E Cryer
Journal:  Diabetes Care       Date:  1997-08       Impact factor: 19.112

2.  An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria.

Authors:  Abigail Liebow; Xingsheng Li; Timothy Racie; Julia Hettinger; Brian R Bettencourt; Nader Najafian; Patrick Haslett; Kevin Fitzgerald; Ross P Holmes; David Erbe; William Querbes; John Knight
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

3.  Pathways of hepatic oxalate synthesis and their regulation.

Authors:  R E Poore; C H Hurst; D G Assimos; R P Holmes
Journal:  Am J Physiol       Date:  1997-01

4.  Hydroxyproline metabolism in mouse models of primary hyperoxaluria.

Authors:  John Knight; Ross P Holmes; Scott D Cramer; Tatsuya Takayama; Eduardo Salido
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-21

5.  Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.

Authors:  M J Lumb; C J Danpure
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.

Authors:  S D Cramer; P M Ferree; K Lin; D S Milliner; R P Holmes
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

Review 7.  The primary hyperoxalurias.

Authors:  Bernd Hoppe; Bodo B Beck; Dawn S Milliner
Journal:  Kidney Int       Date:  2009-02-18       Impact factor: 10.612

8.  Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

Authors:  Sonia Fargue; Dawn S Milliner; John Knight; Julie B Olson; W Todd Lowther; Ross P Holmes
Journal:  J Am Soc Nephrol       Date:  2018-03-27       Impact factor: 10.121

9.  Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.

Authors:  Kyle D Wood; Ross P Holmes; David Erbe; Abigail Liebow; Sonia Fargue; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

10.  Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort.

Authors:  Ronak Jagdeep Shah; Lisa E Vaughan; Felicity T Enders; Dawn S Milliner; John C Lieske
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 6.208

View more
  1 in total

1.  Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD+).

Authors:  Anshula Sharma; Vikrant Mehta; Suman Rani; Masafumi Noda; Masanori Sugiyama; Harish Chander; Baljinder Kaur
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-28       Impact factor: 4.813

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.